Metric Deep Dive: Understanding Cognition Therapeutics Inc (CGTX) Through its Ratios

Kiel Thompson

Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

After finishing at $1.75 in the prior trading day, Cognition Therapeutics Inc (NASDAQ: CGTX) closed at $1.76, up 0.57%. In other words, the price has increased by $0.57 from its previous closing price. On the day, 2.06 million shares were traded. CGTX stock price reached its highest trading level at $1.825 during the session, while it also had its lowest trading level at $1.67.

Ratios:

Our goal is to gain a better understanding of CGTX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.54 and its Current Ratio is at 1.54. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.03.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for the company, B. Riley Securities on December 19, 2024, Upgraded its rating to Buy and sets its target price to $1.50 from $1 previously.

On November 03, 2021, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $22.Oppenheimer initiated its Outperform rating on November 03, 2021, with a $22 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 31 ’25 when Ricciardi Lisa bought 38,851 shares for $0.77 per share. The transaction valued at 30,001 led to the insider holds 38,851 shares of the business.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGTX now has a Market Capitalization of 155274032 and an Enterprise Value of 119036072.

Stock Price History:

The Beta on a monthly basis for CGTX is 1.18, which has changed by 3.3031783 over the last 52 weeks, in comparison to a change of 0.16845357 over the same period for the S&P500. Over the past 52 weeks, CGTX has reached a high of $3.83, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is 4.39%, while the 200-Day Moving Average is calculated to be 121.96%.

Shares Statistics:

The stock has traded on average 10.42M shares per day over the past 3-months and 2330590 shares per day over the last 10 days, according to various share statistics. A total of 88.22M shares are outstanding, with a floating share count of 70.92M. Insiders hold about 19.61% of the company’s shares, while institutions hold 5.95% stake in the company. Shares short for CGTX as of 1757894400 were 9001537 with a Short Ratio of 0.86, compared to 1755216000 on 6226969. Therefore, it implies a Short% of Shares Outstanding of 9001537 and a Short% of Float of 10.99.

Earnings Estimates

As of right now, 4.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.08, with high estimates of -$0.05 and low estimates of -$0.13.

Analysts are recommending an EPS of between -$0.33 and -$0.51 for the fiscal current year, implying an average EPS of -$0.4. EPS for the following year is -$0.28, with 3.0 analysts recommending between -$0.15 and -$0.37.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.